Download PDF
CC BY-NC-ND 4.0 · Dental Journal of Advance Studies 2022; 10(03): 145-149
DOI: 10.1055/s-0042-1757546
Original Article

Effect of Nonsurgical Periodontal Therapy on Adiponectin Levels in Type 2 Diabetics with Moderate to Severe Chronic Periodontitis-A Pilot Trial

Kanika Aggarwal
1   Department of Periodontology, Bhojia Dental College and Hospital, Baddi, Himachal Pradesh, India
,
Shipra Gupta
2   Unit of Periodontics, Oral Health Sciences Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India
,
Shaveta Sood
3   Department of Periodontology, Dr. Harvansh Singh Judge Institute of Dental Sciences & Hospital, Panjab University, Chandigarh, India
,
Nandini Bhaskar
3   Department of Periodontology, Dr. Harvansh Singh Judge Institute of Dental Sciences & Hospital, Panjab University, Chandigarh, India
,
Mili Gupta 
4   Department of Biochemistry, Dr. Harvansh Singh Judge Institute of Dental Sciences & Hospital, Panjab University, Chandigarh, India
,
Vinay Kapur
5   Department of General Medicine, Dr. Harvansh Singh Judge Institute of Dental Sciences & Hospital, Panjab University, Chandigarh, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Background Adiponectin is a novel adipocyte-specific protein, which plays an important role in decreasing insulin resistance and inflammation, and hence can be considered in understanding the underlying mechanisms of both diabetes and periodontitis. As periodontitis and diabetes mellitus share common pathways of pathogenesis, this study was conducted to determine the effect of nonsurgical periodontal therapy on adiponectin levels in type 2 diabetics with moderate to severe chronic periodontitis.

Material and Methods Ten poorly controlled type 2 diabetics (hemoglobin A1c [HbA1c] ≥ 6.5%) with moderate to severe periodontitis (test group) and 10 age, sex, and body mass index matched systemically healthy patients with moderate to severe periodontitis (control group) were recruited. All the subjects underwent nonsurgical periodontal therapy. Gingival crevicular fluid (GCF) and serum were collected at the baseline and 3 months after periodontal treatment for assessment of adiponectin levels.

Results Adiponectin levels increased postperiodontal therapy in both the groups, both in GCF (p = 0.206, 0.12) and serum (p = 0.051, 0.06). HbA1c reduced in the test group posttreatment (p = 0.229).

Conclusion Nonsurgical periodontal therapy affects adiponectin levels locally as well as systemically thereby leading to improvement of glycemic control.

Keywords

adiponectin - chronic periodontitis - type 2 diabetes mellitus - scaling and root planing

Authors' Contributions

A.K., G.S., S.S., and B.N. conceptualized and designed the study. A.K., G.S., S.S., B.N., and K.V. collected the data. A.K., G.S., S.S., B.N., and G.M. conducted the laboratory investigations. A.K., G.S., S.S., B.N., and G.M. analyzed and interpreted the results. A.K., G.S., S.S., and B.N. wrote the manuscript. G.S., S.S., B.N., A.K., and G.M. edited the manuscript and critically reviewed it.


All authors approved the final submitted version of the manuscript. A.K., G.S., S.S., and N.B. are the “guarantors” for the current study. Each author believes that the manuscript represents honest work.


This work belongs to : Department of Periodontics, Dr. Harvansh Singh Judge Institute of Dental Sciences and Hospital, Panjab University, Chandigarh, India




Publication History

Article published online:
12 October 2022

© 2022. Bhojia Dental College and Hospital affiliated to Himachal Pradesh University. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Tan WC, Tay FB, Lim LP. Diabetes as a risk factor for periodontal disease: current status and future considerations. Ann Acad Med Singap 2006; 35 (08) 571-581
    CrossrefPubMedGoogle Scholar
  • 2 Ohlrich EJ, Cullinan MP, Leichter JW. Diabetes, periodontitis, and the subgingival microbiota. J Oral Microbiol 2010; 2: 10
    CrossrefPubMedGoogle Scholar
  • 3 Casarin RC, Barbagallo A, Meulman T. et al. Subgingival biodiversity in subjects with uncontrolled type-2 diabetes and chronic periodontitis. J Periodontal Res 2013; 48 (01) 30-36
    CrossrefPubMedGoogle Scholar
  • 4 Polak D, Sanui T, Nishimura F, Shapira L. Diabetes as a risk factor for periodontal disease-plausible mechanisms. Periodontol 2000 2020; 83 (01) 46-58
    CrossrefPubMedGoogle Scholar
  • 5 Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6 (10) 772-783
    CrossrefPubMedGoogle Scholar
  • 6 Zhu J, Guo B, Gan X. et al. Association of circulating leptin and adiponectin with periodontitis: a systematic review and meta-analysis. BMC Oral Health 2017; 17 (01) 104
    CrossrefPubMedGoogle Scholar
  • 7 Sheng T, Yang K. Adiponectin and its association with insulin resistance and type 2 diabetes. J Genet Genomics 2008; 35 (06) 321-326
    CrossrefPubMedGoogle Scholar
  • 8 Simpson F, Whitehead JP. Adiponectin–it's all about the modifications. Int J Biochem Cell Biol 2010; 42 (06) 785-788
    CrossrefPubMedGoogle Scholar
  • 9 Fagerberg B, Kellis D, Bergström G, Behre CJ. Adiponectin in relation to insulin sensitivity and insulin secretion in the development of type 2 diabetes: a prospective study in 64-year-old women. J Intern Med 2011; 269 (06) 636-643
    CrossrefPubMedGoogle Scholar
  • 10 Engebretson S, Kocher T. Evidence that periodontal treatment improves diabetes outcomes: a systematic review and meta-analysis. J Clin Periodontol 2013; 40 (Suppl. 14) S153-S163
    PubMedGoogle Scholar
  • 11 American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019; 42 (Suppl. 01) S13-S28
    CrossrefPubMedGoogle Scholar
  • 12 Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999; 4 (01) 1-6
    CrossrefPubMedGoogle Scholar
  • 13 Kardeşler L, Buduneli N, Çetinkalp S, Kinane DF. Adipokines and inflammatory mediators after initial periodontal treatment in patients with type 2 diabetes and chronic periodontitis. J Periodontol 2010; 81 (01) 24-33
    CrossrefPubMedGoogle Scholar
  • 14 Griffiths GS. Formation, collection and significance of gingival crevice fluid. Periodontol 2000 2003; 31: 32-42
    CrossrefPubMedGoogle Scholar
  • 15 Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009; 302 (02) 179-188
    CrossrefPubMedGoogle Scholar
  • 16 Liu Z, Liang S, Que S, Zhou L, Zheng S, Mardinoglu A. Meta-analysis of adiponectin as a biomarker for the detection of metabolic syndrome. Front Physiol 2018; 9: 1238
    CrossrefPubMedGoogle Scholar
  • 17 Sun WL, Chen LL, Zhang SZ, Ren YZ, Qin GM. Changes of adiponectin and inflammatory cytokines after periodontal intervention in type 2 diabetes patients with periodontitis. Arch Oral Biol 2010; 55 (12) 970-974
    CrossrefPubMedGoogle Scholar
  • 18 Natalina, Masulili SLC, Harsas NA, Subekti I, Auerkari EI. Gingival crevicular fluid levels of resistin and adiponectin in chronic periodontitis with type 2 diabetes mellitus. J Int Dent Med Res 2016; 9: x
    PubMedGoogle Scholar
  • 19 Cao H. Adipocytokines in obesity and metabolic disease. J Endocrinol 2014; 220 (02) T47-T59
    CrossrefPubMedGoogle Scholar
  • 20 Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008; 29 (24) 2959-2971
    CrossrefPubMedGoogle Scholar
  • 21 Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes 2003; 52 (07) 1779-1785
    CrossrefPubMedGoogle Scholar
  • 22 Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF. Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-α is obligatory. Diabetes 2002; 51 (05) 1319-1336
    CrossrefPubMedGoogle Scholar
  • 23 Fantuzzi G. Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol 2008; 121 (02) 326-330
    CrossrefPubMedGoogle Scholar
  • 24 Ghalwash DM, Shaker OG, Mahmoud EA. Local and systemic level of adipokines as markers of inflammation in periodontitis and type 2 diabetes mellitus after periodontal therapy. Tanta Dent J 2019; 16: 104
    CrossrefPubMedGoogle Scholar
  • 25 Genco RJ, Borgnakke WS. Risk factors for periodontal disease. Periodontol 2000 2013; 62 (01) 59-94
    CrossrefPubMedGoogle Scholar
  • 26 Tanwar J, Hungund SA, Dodani K. Nonsurgical periodontal therapy: a review. J Oral Res Rev 2016; 8: 39
    CrossrefPubMedGoogle Scholar
  • 27 Sabharwal A, Gomes-Filho IS, Stellrecht E, Scannapieco FA. Role of periodontal therapy in management of common complex systemic diseases and conditions: an update. Periodontol 2000 2018; 78 (01) 212-226
    CrossrefPubMedGoogle Scholar